ESR1 and breast carcinoma: In our in vitro system, both estrogen-receptor positive and estrogen-receptor negative tumor cells are responsive to type I interferons, but the ability to induce expression of interferons in co-cultivated fibroblasts was specific to the estrogen-receptor negative breast cancer cells.